TATAA Biocenter is expanding its offerings of high-throughput gene expression profiling using Roche's qPCR assays and panels
The group's laboratories provide contract research for a range of real-time qPCR services, including primer and probe design, validation, data analysis, and kit and instrument evaluation to pharmaceutical and biotech companies.
"The number of genes researchers characterise in a given sample is steadily increasing", said Dr Mikael Kubista, founder and CEO of TATAA Biocenter.
"In response to this demand, we now offer high-throughput profiling services in a complete workflow from nucleic acid extraction, gene profiling, and data mining." After extensive testing and validation of various offerings on the market, the group selected the Roche RealTime ready platform for its performance combined with GenEx from MultiD analysis.
